PHASE-I EVALUATION OF CHLOROZOTOCIN (NSC-178248) - WEEKLY SCHEDULE

被引：0
|
作者：
MORICONI, WJ
TAYLOR, S
SLAVIK, M
BELT, RJ
HAAS, CD
HOOGSTRATEN, B
机构：
[1] UNIV KANSAS,MED CTR,DEPT MED,DIV CLIN ONCOL,KANSAS CITY,KS 66103
[2] VET ADM MED CTR,KANSAS CITY,MO 64128
来源：
INVESTIGATIONAL NEW DRUGS | 1985年 / 3卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：57 / 62
页数：6
相关论文
共 50 条
  • [41] PHASE-I AND PHARMACOKINETIC STUDY OF HEPSULFAM (NSC 329680)
    HENDRICKS, CB
    GROCHOW, LB
    ROWINSKY, EK
    FORASTIERE, AA
    MCGUIRE, WP
    ETTINGER, DS
    SARTORIUS, S
    LUBEJKO, B
    DONEHOWER, RC
    CANCER RESEARCH, 1991, 51 (21) : 5781 - 5785
  • [42] PHASE-I STUDY AND PHARMACOKINETICS OF TAXOL (NSC 125973)
    SCHWARTZ, EL
    ENGEL, SI
    STRAUMAN, JJ
    WIERNIK, PH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 227 - 227
  • [43] PHASE-I STUDY OF ANGUIDINE (DIACETOXYSCIRPENOL NSC 1415377)
    HAAS, C
    GOODWIN, W
    LEITE, C
    STEPHENS, R
    HOOGSTRATEN, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 296 - 296
  • [44] PHASE-I STUDY OF ANGUIDINE ADMINISTERED WEEKLY
    BELT, RJ
    HAAS, CD
    JOSEPH, U
    GOODWIN, W
    MOORE, D
    HOOGSTRATEN, B
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 1993 - 1995
  • [45] PHASE-I CLINICAL-TRIAL OF THE GLUTAMINE ANTAGONIST DON (NSC 7365) ON A 5-DAY SCHEDULE
    EARHART, RH
    KOELLER, JM
    DAVIS, HL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 190 - 190
  • [46] PHASE-I AND PHARMACOKINETIC STUDY OF THE CAMPTOTHECIN DERIVATIVE IRINOTECAN, ADMINISTERED ON A WEEKLY SCHEDULE IN CANCER-PATIENTS
    DEFORNI, M
    BUGAT, R
    CHABOT, GG
    CULINE, S
    EXTRA, JM
    GOUYETTE, A
    MADELAINE, I
    MARTY, ME
    MATHIEUBOUE, A
    CANCER RESEARCH, 1994, 54 (16) : 4347 - 4354
  • [47] PHASE-I TRIAL OF CHLOROZOTOCIN - ATTEMPTED AMELIORATION OF MYELOTOXICITY BY GLUCOSE-ADMINISTRATION
    PANASCI, L
    COMIS, R
    GINSBERG, S
    KOHN, L
    FITZPATRICK, A
    RUBERT, M
    SCALZO, T
    CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 647 - 650
  • [48] A PHASE-I TRIAL OF TRIMETREXATE (NSC352122) ON A DAILY X 5 SCHEDULE IN PATIENTS WITH REFRACTORY ADULT LEUKEMIA
    RODRIGUEZ, G
    BROWN, TD
    BALIS, FM
    CRAIG, JB
    DENHAM, CA
    KUHN, JG
    HAVLIN, K
    VONHOFF, DD
    ANTI-CANCER DRUGS, 1993, 4 (02) : 163 - 166
  • [49] PHASE-I CLINICAL-TRIAL WITH PHARMACOKINETIC ANALYSIS OF ACODAZOLE (NSC-305885) GIVEN BY WEEKLY IV INFUSION
    TUTSCH, KD
    ALBERTI, D
    KOELLER, J
    WILLSON, JKV
    BORDEN, EC
    RAMIREZ, G
    TORMEY, DC
    TRUMP, DL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 176 - 176
  • [50] PHASE-I STUDY OF L-ASPARAGINASE (NSC 109229)
    WILSON, WL
    WEISS, AJ
    RAMIREZ, G
    ONCOLOGY, 1975, 32 (3-4) : 109 - 117
12345